252 related articles for article (PubMed ID: 14645110)
1. Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin.
Mabuchi S; Ohmichi M; Kimura A; Ikebuchi Y; Hisamoto K; Arimoto-Ishida E; Nishio Y; Takahashi K; Tasaka K; Murata Y
Endocrinology; 2004 Mar; 145(3):1302-13. PubMed ID: 14645110
[TBL] [Abstract][Full Text] [Related]
2. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
3. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
Mandlekar S; Yu R; Tan TH; Kong AN
Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519
[TBL] [Abstract][Full Text] [Related]
4. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y
Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
Lee TH; Chuang LY; Hung WC
Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
[TBL] [Abstract][Full Text] [Related]
6. Influence of tamoxifen on cisplatin-sensitivity and estrogen receptors expression in ovarian carcinoma cell lines.
Nowak-Markwitz E; Maciejczyk A; Pudełko M; Tserenchunt G; Balázs G; Spaczyński M; Zabel M; Dietel M; Lage H; Surowiak P
Ginekol Pol; 2010 Mar; 81(3):183-7. PubMed ID: 20486538
[TBL] [Abstract][Full Text] [Related]
7. [Effect of mitogen-activated protein kinase signal transduction in non-estrogen antagonistic mechanism of tamoxifen].
Yang D; Wang S; Wang S; Ye Y; Cui Z
Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1232-4. PubMed ID: 12425799
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line.
Hayakawa J; Ohmichi M; Kurachi H; Ikegami H; Kimura A; Matsuoka T; Jikihara H; Mercola D; Murata Y
J Biol Chem; 1999 Oct; 274(44):31648-54. PubMed ID: 10531373
[TBL] [Abstract][Full Text] [Related]
9. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines.
Cui W; Yazlovitskaya EM; Mayo MS; Pelling JC; Persons DL
Mol Carcinog; 2000 Dec; 29(4):219-28. PubMed ID: 11170260
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-dependent and estrogen receptor-independent pathways for tamoxifen and 4-hydroxytamoxifen-induced programmed cell death.
Obrero M; Yu DV; Shapiro DJ
J Biol Chem; 2002 Nov; 277(47):45695-703. PubMed ID: 12244117
[TBL] [Abstract][Full Text] [Related]
12. Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.
Li Z; Wang N; Fang J; Huang J; Tian F; Li C; Xie F
Oncol Rep; 2012 Jun; 27(6):1879-86. PubMed ID: 22427054
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
Hutcheson IR; Knowlden JM; Madden TA; Barrow D; Gee JM; Wakeling AE; Nicholson RI
Breast Cancer Res Treat; 2003 Sep; 81(1):81-93. PubMed ID: 14531500
[TBL] [Abstract][Full Text] [Related]
14. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
[TBL] [Abstract][Full Text] [Related]
15. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity.
Chuang SM; Liou GY; Yang JL
Carcinogenesis; 2000 Aug; 21(8):1491-500. PubMed ID: 10910949
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y
Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH
Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin E on tamoxifen-treated breast cancer cells.
Peralta EA; Viegas ML; Louis S; Engle DL; Dunnington GL
Surgery; 2006 Oct; 140(4):607-14; discussion 614-5. PubMed ID: 17011908
[TBL] [Abstract][Full Text] [Related]
19. Involvement of histone H3 phosphorylation through p38 MAPK pathway activation in casticin-induced cytocidal effects against the human promyelocytic cell line HL-60.
Kikuchi H; Yuan B; Yuhara E; Takagi N; Toyoda H
Int J Oncol; 2013 Dec; 43(6):2046-56. PubMed ID: 24064676
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of tamoxifen-induced apoptosis.
Mandlekar S; Kong AN
Apoptosis; 2001 Dec; 6(6):469-77. PubMed ID: 11595837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]